Works matching IS 03407004 AND DT 2003 AND VI 52 AND IP 12
Results: 6
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 739, doi. 10.1007/s00262-003-0405-8
- By:
- Publication type:
- Article
Naturally occurring B-cell responses to breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 715, doi. 10.1007/s00262-003-0409-4
- By:
- Publication type:
- Article
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 751, doi. 10.1007/s00262-003-0410-y
- By:
- Publication type:
- Article
Identification of new MHC-restriction elements for presentation of the p210<sup>BCR-ABL</sup> fusion region to human cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 761, doi. 10.1007/s00262-003-0415-6
- By:
- Publication type:
- Article
Natural CD8<sup>+</sup> T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 771, doi. 10.1007/s00262-003-0420-9
- By:
- Publication type:
- Article
Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 780, doi. 10.1007/s00262-003-0421-8
- By:
- Publication type:
- Article